📗 Cite This Artifact
rpl21
rpl21
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">rpl21</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RPL21</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ribosomal Protein L21</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>13q12.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6147</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000122026</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P63220</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>160 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>18.5 kDa</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
RPL21 (Ribosomal Protein L21) is a component of the 60S large ribosomal subunit, playing a critical role in protein synthesis and cellular homeostasis. Mutations in RPL21 have been associated with Diamond-Blackfan anemia (DBA), and ribosomal dysfunction is increasingly recognized as a contributing factor to neurodegenerative diseases including Alzheimer's and Parkinson's disease.
Gene Overview
Gene Structure
The RPL21 gene contains:
- 7 exons spanning approximately 4.5 kb
- Multiple transcriptional start sites
- Alternative splicing producing different isoforms
Regulation of Expression
...
rpl21
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">rpl21</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RPL21</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ribosomal Protein L21</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>13q12.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6147</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000122026</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P63220</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>160 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>18.5 kDa</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
RPL21 (Ribosomal Protein L21) is a component of the 60S large ribosomal subunit, playing a critical role in protein synthesis and cellular homeostasis. Mutations in RPL21 have been associated with Diamond-Blackfan anemia (DBA), and ribosomal dysfunction is increasingly recognized as a contributing factor to neurodegenerative diseases including Alzheimer's and Parkinson's disease.
Gene Overview
Gene Structure
The RPL21 gene contains:
- 7 exons spanning approximately 4.5 kb
- Multiple transcriptional start sites
- Alternative splicing producing different isoforms
Regulation of Expression
RPL21 expression is regulated at multiple levels:
Protein Structure and Function
Structure
RPL21 is a 18.5 kDa protein consisting of 160 amino acids. It is located on the 60S ribosomal subunit and contributes to the structural and functional integrity of the ribosome.
Function
Role in Neurodegeneration
Ribosomal Dysfunction in Alzheimer's Disease
Ribosomal dysfunction is a hallmark of Alzheimer's disease pathology[@ding2018]:
- Protein Synthesis Impairment: AD neurons show severely impaired protein synthesis capacity
- [Amyloid-beta](/proteins/amyloid-beta) toxicity affects ribosomal RNA synthesis
- [Tau](/proteins/tau-protein) pathology disrupts ribosomal function through multiple mechanisms
- rRNA Transcription Defects: Reduced rRNA synthesis in affected neurons
- Ribosome Aggregation: Abnormal ribosomal assemblies observed in AD brains
The ribosomal dysfunction in AD is characterized by:
Parkinson's Disease and Ribosomal Stress
Dopaminergic neurons are particularly vulnerable to ribosomal dysfunction[@abdullah2018]:
- Metabolic Demands: High protein synthesis requirements make these neurons dependent on efficient ribosomal function
- [Alpha-synuclein](/proteins/alpha-synuclein) aggregation may impair ribosomal activity
- Integrated Stress Response: Activation of ISR pathways in PD models
- Mitochondrial Connection: Ribosomal dysfunction intersects with mitochondrial impairment
- Toxin Sensitivity: MPTP and other PD toxins target ribosomal function
Key mechanisms include:
Mechanism: Ribosomal Stress in Neurodegeneration
Disease Associations
Diamond-Blackfan Anemia
RPL21 mutations are a rare cause of DBA:
- Haploinsufficiency: DBA typically results from loss-of-function mutations
- Phenotype: Similar to other ribosomal protein mutations (RPS19, RPS26)
- p53 Activation: Ribosomal stress triggers p53-dependent cell cycle arrest and apoptosis
Ribosomal Structure and Function
Position in the 60S Subunit
RPL21 is a component of the large (60S) ribosomal subunit[@hetzel2013]. It is located in the ribosome structure at a position that:
- Contributes to the peptidyl transferase center
- Interacts with the exit tunnel for nascent polypeptides
- Participates in ribosome-associated quality control
Ribosomal Protein Families
RPL21 belongs to the ribosomal protein L21E family, which includes:
- RPL21: Eukaryotic 60S ribosomal protein L21
- L27: Prokaryotic ribosomal protein L27
- L36: Bacterial ribosomal protein L36
The eukaryotic ribosomal proteins evolved from prokaryotic ancestors but acquired additional domains and regulatory functions.
Role in Translation
RPL21 participates in several aspects of protein synthesis[@onami2020]:
Ribosomal Dysfunction in Neurodegeneration
Protein Synthesis Impairment in AD
Alzheimer's disease is characterized by severe impairment of protein synthesis in affected neurons[@liu2017]. Key observations include:
- rRNA Loss: Amyloid-beta reduces ribosomal RNA synthesis
- Ribosome Aggregation: Abnormal ribosomal assemblies in AD brains
- Translation Inhibition: Global translation repression in neurons
- mRNA-Specific Effects: Certain mRNAs are more affected than others
Ribosomal Stress in PD
Dopaminergic neurons are particularly vulnerable to ribosomal dysfunction[@abdullah2018]:
- Metabolic Demands: High protein synthesis requirements
- Alpha-synuclein Toxicity: Aggregates may impair ribosomal activity
- Integrated Stress Response: Global translational repression
- Mitochondrial Link: Ribosomal dysfunction intersects with mitochondrial impairment
Ribosomal Protein Deficiencies
Multiple ribosomal proteins have been implicated in neurodegeneration[@khashwji2020]:
- RPS6: Reduced phosphorylation in AD brains
- RPL23: Altered expression in Parkinson's disease
- RPL3: Decreased in ALS motor neurons
- RPS14: Haploinsufficiency causes p53 activation
The Integrated Stress Response (ISR)
Ribosomal stress activates the [integrated stress response](/mechanisms/integrated-stress-response)[@paris2019]:
Synaptic Protein Synthesis
Activity-Dependent Translation
Synaptic plasticity requires rapid protein synthesis at synapses[@yew2018]:
- Local Translation: Ribosomes localized to dendritic spines
- mRNA Transport: Specific mRNAs transported to synapses
- Synaptic Tagging: Activity-dependent recruitment of translation machinery
Ribosomal Dysfunction in Synaptic Plasticity
Ribosomal impairment affects learning and memory:
- Long-Term Potentiation (LTP): Requires new protein synthesis
- Long-Term Depression (LTD): Also translation-dependent
- Memory Consolidation: Disrupted by ribosomal dysfunction
- Synaptic Scaling: Homeostatic plasticity requires translation
Animal Models and Experimental Findings
RPL21 Knockout Models
RPL21 deficiency in animal models reveals:
- Embryonic Lethality: Complete knockout is lethal
- Tissue-Specific Knockouts: Reveal tissue-specific requirements
- Marrow Failure: Similar to DBA phenotype
- Neurological Deficits: Learning and memory impairments
Ribosomal Modulators
Several compounds affect ribosomal function:
- Rapamycin: mTOR inhibitor, reduces translation
- Cycloheximide: Translation inhibitor
- Puromycin: Causes premature termination
- Gentamicin: Affects decoding fidelity
Biomarker Potential
Ribosomal dysfunction markers in neurodegenerative diseases[@zhou2015]:
- CSF Ribosomal Proteins: Elevated in some neurodegenerative conditions
- Blood Ribosomal Markers: Potential peripheral biomarkers
- Translation Assays: Functional measures of ribosomal activity
- p53 Activation: Downstream marker of ribosomal stress
Therapeutic Strategies
Targeting Ribosomal Dysfunction
Several therapeutic approaches are being explored[@ding2018]:
Pharmacological Approaches
- Sodium Salicylate: Inhibits eIF2α phosphorylation
- ISRIB: Integrated stress response inhibitor
- Ribosome-Targeting Antibiotics: Some show neuroprotective effects
Preclinical Studies
Animal models have shown promise for several approaches:
- ISRIB (Integrated Stress Response Inhibitor): Improves cognitive function in AD models
- mTOR Modulators: Rapamycin shows benefits in some models
- Ribosomal Biogenesis Promoters: rRNA synthesis enhancers
Clinical Considerations
Challenges in translating ribosomal therapies include:
- Blood-Brain Barrier: Achieving sufficient CNS penetration
- Specificity: Avoiding effects on systemic translation
- Timing: Optimal intervention window in disease progression
- Combination: Targeting multiple aspects of ribosomal dysfunction
Research Directions
Biomarker Development
Current research focuses on:
- Peripheral Biomarkers: Blood-based ribosomal markers
- Imaging: PET ligands for ribosomal function
- Functional Assays: Translation capacity measurements
Gene Therapy
Viral vector approaches are being explored:
- AAV Delivery: Adeno-associated virus for CNS delivery
- Ribosomal Protein Expression: Restoring RPL21 levels
- Combination Approaches: Multiple ribosomal proteins
Comparative Biology
Evolution of RPL21
RPL21 is highly conserved across species:
- Yeast: Rpl21p, essential for viability
- Zebrafish: Conserved sequence and function
- Mice: Essential for embryonic development
- Humans: Same basic function with additional regulatory complexity
Species-Specific Features
The evolution of RPL21 reveals:
- Conservation of core ribosomal functions
- Acquisition of tissue-specific regulation
- Expansion of protein-protein interaction networks
Ribosomal Protein Interactions
RPL21 interacts with several other ribosomal proteins and factors[@scheffner2019]:
- RPL23: Proximity in the 60S subunit
- RPL3: Cooperative function in translation
- RPL4: Structural interaction
- RPL18: Exit tunnel region
- Ribosome-associated proteins: Quality control factors
These interactions are important for:
See Also
- [Ribosome Biogenesis Pathway](/mechanisms/ribosome-biogenesis)
- [Protein Synthesis Machinery](/mechanisms/protein-synthesis)
- [Integrated Stress Response](/mechanisms/integrated-stress-response)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Protein Quality Control](/mechanisms/protein-quality-control)
External Links
- [NCBI Gene: RPL21](https://www.ncbi.nlm.nih.gov/gene/6147)
- [UniProt: P63220](https://www.uniprot.org/uniprot/P63220)
- [Ensembl: ENSG00000122026](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000122026)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-rpl21 |
| kg_node_id | RPL21 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-60389f112f3e |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-rpl21'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-rpl21?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[rpl21](http://scidex.ai/artifact/wiki-genes-rpl21)
http://scidex.ai/artifact/wiki-genes-rpl21